← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2009-08-07

Drug application

FDA Application #
ANDA078818
Application type
Abbreviated New Drug Application (Generic)
Brand name
OXALIPLATIN
Generic name
Oxaliplatin
Active ingredients
OXALIPLATIN
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Discontinued
Sponsor
SUN PHARM
First approval
2009-08-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown